Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up

B. Vijayakumar (London, United Kingdom), J. Tonkin (London, United Kingdom), A. Devaraj (London, United Kingdom), K. Philip (London, United Kingdom), C. Orton (London, United Kingdom), S. Desai (London, United Kingdom), P. Shah (London, United Kingdom)

Source: Virtual Congress 2021 – Long COVID - 19
Session: Long COVID - 19
Session type: E-poster
Number: 1155

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Vijayakumar (London, United Kingdom), J. Tonkin (London, United Kingdom), A. Devaraj (London, United Kingdom), K. Philip (London, United Kingdom), C. Orton (London, United Kingdom), S. Desai (London, United Kingdom), P. Shah (London, United Kingdom). Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up. 1155

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study
Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018
Year: 2019



The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018
Year: 2019



Early symptoms in suspected lung cancer: a prospective cohort study
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020



Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study
Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021
Year: 2022



Early childhood growth is associated with lung function at 7 years: a prospective population-based study
Source: Eur Respir J, 56 (6) 2000157; 10.1183/13993003.00157-2020
Year: 2020



Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study
Source: Eur Respir J 2004; 24: Suppl. 48, 254s
Year: 2004

An observational study of the lung clearance index throughout childhood in cystic fibrosis: early years matter
Source: Eur Respir J, 56 (4) 2000006; 10.1183/13993003.00006-2020
Year: 2020



Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Predictors of lung function decline: a retrospective study in COPD patients
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018
Year: 2019



Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study.
Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence
Year: 2021



Is lung function worsening during adolescence in cystic fibrosis? A retrospective study
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012


Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020